Skip to content

For laboratory research use only — not for human or veterinary use

Home / Learn / Compounds

CompoundsResearch guide

Retatrutide (LY3437943): A Research Overview

What retatrutide is, the receptor systems it engages, and how research material is characterized and documented.

By TagPep Editorial Team · Published June 11, 2026

Retatrutide, also designated LY3437943, is a synthetic peptide studied as a triple-receptor agonist. In published preclinical and clinical research it is described as engaging three incretin and metabolic receptor systems at once — the GLP-1, GIP, and glucagon receptors. That multi-receptor profile is what distinguishes it from single- and dual-agonist research compounds.

Identity and molecular data

  • Compound: Retatrutide (LY3437943)
  • CAS: 2381609-61-4
  • Molecular weight: approximately 4,731 Da
  • Format: lyophilized (freeze-dried) powder, supplied as a sealed research vial

These identifiers let a laboratory confirm that received material matches what was ordered. A batch Certificate of Analysis reports identity — typically by liquid chromatography–mass spectrometry — and reported chromatographic purity by HPLC, tied to a specific lot number.

Why the triple-receptor profile matters to researchers

Single-receptor and multi-receptor agonists are studied as distinct tools. Because retatrutide engages glucagon-receptor signaling in addition to the two incretin receptors, it is used in research models examining the combined pharmacology of these pathways. TagPep does not make, and researchers should not infer, any claim about clinical outcomes — published findings belong to the underlying studies, not to a supplied research material.

Documentation and handling

Research-grade material is only as useful as its documentation. Before using retatrutide in any workflow, confirm that the lot number on the vial matches the lot on the available analytical report, and follow general storage and handling guidance for lyophilized peptides. Reported purity from HPLC describes the proportion of the target compound among detected peaks; it does not, by itself, establish sterility or freedom from every possible contaminant. See identity, purity and quantity for why these are three separate measurements.

The TagPep Retatrutide 60 mg research vial is supplied with batch-linked documentation for laboratory research use only.

For laboratory research use only. Not for human or veterinary use. Not for human consumption. Not for diagnostic or therapeutic use.

Frequently asked questions

What is retatrutide used for in research?

Retatrutide (LY3437943) is a synthetic triple-receptor agonist studied in preclinical and clinical research for its activity at the GLP-1, GIP, and glucagon receptors. TagPep supplies it strictly as a research-use-only reference material — not for human or veterinary use.

What molecular data identifies retatrutide?

Retatrutide carries CAS number 2381609-61-4 and a molecular weight of approximately 4,731 Da. A batch Certificate of Analysis reports identity by mass spectrometry and reported purity by HPLC for the specific lot supplied.

Catalog

Looking for research compounds?

Browse TagPep's catalog of research peptides and laboratory compounds, supplied with available batch documentation for laboratory research use only.

Browse research compounds

Educational content for research reference only — not medical, veterinary, or personal-use advice. Products referenced are research compounds supplied for laboratory research use only and are not intended for human or veterinary use.